Cargando…
Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis
BACKGROUND: Parthenolide has anti-inflammatory, immunomodulatory and anti-cancer activities. But its effect on thyroid cancer cells is still largely unknown. METHODS: Label-free quantitative proteomics and bioinformatics analysis were used to investigate the differentially expressed proteins and the...
Autores principales: | Cui, Meng, Wang, Zhe, Huang, Le-Tian, Wang, Jia-He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977004/ https://www.ncbi.nlm.nih.gov/pubmed/35366876 http://dx.doi.org/10.1186/s12906-022-03579-0 |
Ejemplares similares
-
Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells
por: Huang, Le-Tian, et al.
Publicado: (2023) -
Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro
por: Liu, Jun-Wei, et al.
Publicado: (2010) -
Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis
por: Liu, Weifeng, et al.
Publicado: (2017) -
Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
por: Jorge, Joana, et al.
Publicado: (2023) -
Trends in parthenolide research over the past two decades: A bibliometric analysis
por: Liu, Jiye, et al.
Publicado: (2023)